Literature DB >> 6661467

Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normals.

S I Deutsch, R C Mohs, M I Levy, A B Rothpearl, D Stockton, T Horvath, A Coco, K L Davis.   

Abstract

Acetylcholinesterase (AChE) activity and protein were measured in the CSF of patients with Alzheimer's disease, depression, schizophrenia with and without tardive dyskinesia, and control subjects. AChE activity was assayed by a radioenzymatic method involving the direct extraction of hydrolyzed 3H-acetate into a toluene-based scintillation fluid followed by liquid scintillation spectrometry. AChE activity was proportional to the amount of CSF protein. Greater than 90% of AChE activity in CSF could be inhibited by 10(-3) M eserine. In addition, activity remained stable despite repeated freeze-thawing in an acetone-dry ice bath. Age was found to be positively correlated with CSF protein and AChE activity expressed per volume CSF, but not with AChE measured per milligram protein. No differences between diagnostic groups were found on either measure of AChE when the extraneous factors of age and CSF protein concentrations were controlled, nor were any differences found between groups for CSF protein when age was controlled.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661467

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

1.  Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data.

Authors:  K J Reinikainen; P J Riekkinen; L Paljärvi; H Soininen; E L Helkala; J Jolkkonen; M Laakso
Journal:  Neurochem Res       Date:  1988-02       Impact factor: 3.996

2.  Serum and CSF cholinesterase activity in various kinds of dementia.

Authors:  A K Szilágyi; A Németh; E Martini; B Lendvai; V Venter
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

Review 3.  Acetylcholine and affective disorder.

Authors:  S S Leong; W A Brown
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

4.  Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.

Authors:  P Hartikainen; H Soininen; K J Reinikainen; J Sirviö; R Soikkeli; P J Riekkinen
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 5.  Status of cholinesterase activities in blood in neuropsychiatric disorders.

Authors:  S I Deutsch; M Campbell
Journal:  Neurochem Res       Date:  1984-07       Impact factor: 3.996

6.  Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.

Authors:  B V Manyam; E Giacobini; J A Colliver
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

7.  Acetylcholine synthesis in human CSF: implications for study of central cholinergic metabolism.

Authors:  S T DeKosky; S W Scheff; C G Hackney
Journal:  Neurochem Res       Date:  1989-02       Impact factor: 3.996

8.  Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.

Authors:  M Ruberg; A Villageois; A M Bonnet; B Pillon; F Rieger; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

9.  Evidence of upregulation of the cholinergic anti-inflammatory pathway in late-life depression.

Authors:  Nunzio Pomara; Davide Bruno; Chelsea Reichert Plaska; Anilkumar Pillai; Jaime Ramos-Cejudo; Ricardo Osorio; Bruno P Imbimbo; Amanda Heslegrave; Henrik Zetterberg; Kaj Blennow
Journal:  J Affect Disord       Date:  2021-03-09       Impact factor: 4.839

10.  Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.

Authors:  Sonja Orlovska-Waast; Ole Köhler-Forsberg; Sophie Wiben Brix; Merete Nordentoft; Daniel Kondziella; Jesper Krogh; Michael Eriksen Benros
Journal:  Mol Psychiatry       Date:  2018-08-16       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.